Back to compounds

COMPOUND PROFILE / SMALL MOLECULES

CMS121.

Research draft

CMS121 is an experimental fisetin-derived small molecule investigated in neurodegeneration.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Overview

CMS121 is an experimental fisetin-derived small molecule investigated in neurodegeneration.

CLASSIFICATIONSmall molecules
MOLECULAR / SEQUENCE INFONot specified
PRIMARY CONTEXTCompound

Mechanism

It affects lipid-metabolism and cellular stress pathways, including fatty acid synthase-related activity.

Human research

A published phase 1 healthy-volunteer study examines safety and pharmacokinetics; it does not establish dementia efficacy.

Preclinical & other research

Mouse models reported cognitive and inflammatory effects.

Safety & unknowns

Early exposure data cannot settle long-term safety in older patients or disease populations.

Regulatory status

Investigational; the earlier description of exclusively preclinical evidence is outdated.

Reported use & evidence

Research profile draft

The supplied CMS121 profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds